文献速递白血病造血干细胞移植与细胞治疗

急性髓系白血病患者骨髓间充质干细胞展现成脂分化倾向并支持白血病细胞

Bone marrow mesenchymal stromal cells from acute myelogenous leukemia patients demonstrate adipogenic differentiation propensity with implications for leukemia cell support.
PubMed 文献 · Leukemia · 2019-09-06

该研究比较正常供者与急性髓系白血病(AML)患者来源的骨髓间充质干细胞(MSCs),发现AML-MSCs成脂分化潜力增强且支持白血病祖细胞存活能力提高。RNA-Seq分析显示成脂相关通路失调,SOX9和EGR2表达降低。提高SOX9表达可降低AML-MSCs成脂潜力及对AML祖细胞的支持能力。

要点

  • AML患者骨髓MSCs成脂分化潜力高于正常供者MSCs。
  • AML-MSCs支持白血病祖细胞存活的能力增强。
  • SOX9和EGR2在AML-MSCs中表达降低,提高SOX9可逆转上述表型。

核心结论

  • AML-MSCs具有增强的成脂分化潜力,可能促进对白血病祖细胞的支持。

研究设计与样本

  • 比较正常供者(ND)与急性髓系白血病(AML)患者来源的骨髓间充质干细胞(MSCs),并进行RNA-Seq分析。

主要发现

  • AML-MSCs成脂潜力增加,支持白血病祖细胞存活的能力提高。
  • RNA-Seq的基因本体和通路分析显示成脂是AML-MSCs中失调的生物通路之一。
  • 与ND-MSCs相比,AML-MSCs中SOX9和EGR2表达降低。
  • 提高SOX9表达降低AML-MSCs的成脂潜力及其支持AML祖细胞的能力。

临床怎么用

  • 提示靶向AML-MSCs的成脂分化或SOX9/EGR2通路可能削弱其对白血病祖细胞的支持。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Bone marrow mesenchymal stromal cells (MSCs) constitute one of the important components of the hematopoietic microenvironmental niche. In vivo studies have shown that depletion of marrow MSCs resulted in reduction of hematopoietic stem cell content, and there is in vitro evidence that marrow MSCs are able to support leukemia progenitor cell proliferation and survival and provide resistance to cytotoxic therapies. How MSCs from leukemia marrow differ from normal counterparts and how they are influenced by the presence of leukemia stem and progenitor cells are still incompletely understood. In this work, we compared normal donor (ND) and acute myelogenous leukemia (AML) derived MSCs and found that AML-MSCs had increased adipogenic potential with improved ability to support survival of leukemia progenitor cells. To identify underlying changes, RNA-Seq analysis was performed. Gene ontology and pathway analysis revealed adipogenesis to be among the set of altered biological pathways dysregulated in AML-MSCs as compared with ND-MSCs. Expression of both SOX9 and EGR2 was decreased in AML-MSCs as compared with ND-MSCs. Increasing expression of SOX9 decreased adipogenic potential of AML-MSCs and decreased their ability to support AML progenitor cells. These findings suggest that AML-MSCs possess adipogenic potential which may enhance support of leukemia progenitor cells.

来源:Leukemia,查看原文。版权归原作者所有。

引用

  1. Azadniv M, Myers JR, McMurray HR, et al. Bone marrow mesenchymal stromal cells from acute myelogenous leukemia patients demonstrate adipogenic differentiation propensity with implications for leukemia cell support. Leukemia. 2019. PMID: 31492897. doi:10.1038/s41375-019-0568-8

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。